LPAR5 as a prospective therapeutic target for treating microvillus inclusion disease
- PMID: 40304314
- PMCID: PMC12113019
- DOI: 10.1080/14728222.2025.2500416
LPAR5 as a prospective therapeutic target for treating microvillus inclusion disease
Keywords: Congenital diarrhea and enteropathy (CODE); enteroid; lysophosphatidic acid; mouse model; small intestine.
Conflict of interest statement
Declaration of interest
I Kaji is a named inventor on a patent application related to this research and owned by the Vanderbilt University. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources